加州大学洛杉矶分校研究人员创造非侵入性直细胞肾癌成像技术,敏感度为85.5%,特殊度为87%。 UCLA researchers create non-invasive clear-cell kidney cancer imaging technique with 85.5% sensitivity and 87% specificity.
加州大学洛杉矶分校琼森综合癌症中心的研究人员开发了一种无创成像技术，可以准确检测透明细胞肾细胞癌，这是最常见的肾癌。 Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a non-invasive imaging technique that accurately detects clear-cell renal cell carcinoma, the most common kidney cancer. 使用针对CA9蛋白质的抗体药物89Zr-TLX250,该方法表现出85.5%的敏感性和87%的特性。 Utilizing the antibody drug 89Zr-TLX250, which targets the CA9 protein, the method shows 85.5% sensitivity and 87% specificity. 这一进展可减少不必要的外科手术,提高治疗准确性,有可能改变肾癌诊断和管理。 This advancement could reduce unnecessary surgeries and improve treatment accuracy, potentially transforming kidney cancer diagnostics and management.